Literature DB >> 26198931

The effect of proinflammatory cytokines in Cognitive Behavioral Therapy.

Fernanda Pedrotti Moreira1, Taiane de Azevedo Cardoso1, Thaíse Campos Mondin1, Luciano Dias de Mattos Souza1, Ricardo Silva1, Karen Jansen1, Jean Pierre Oses1, Carolina David Wiener2.   

Abstract

Major depressive disorder (MDD) is a debilitating disorder and its pathophysiology is associated with deregulation of the immune system. We investigated the changes in circulating levels of proinflammatory cytokines (specifically IL-6 and TNF-α) measured by the ELISA kit in two psychotherapeutic interventions for MDD: Narrative Cognitive Therapy (NCT) and Cognitive Behavioral Therapy (CBT). This is a randomized clinical trial including 97 individuals (18 to 29years-old) with MDD. In CBT there was a significant difference in serum levels of IL-6 and TNF-α, therefore indicating that CBT was more effective than NCT on serum levels proinflammatory cytokines.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive Behavioral Therapy (CBT); Depression; Interleukin-6 (IL-6); Proinflammatory cytokines; Tumor necrosis factor alpha (TNF-α)

Mesh：

Substances：

Year:  2015        PMID： 26198931     DOI： 10.1016/j.jneuroim.2015.06.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


  16 in total

1.  Tumor Mutation Burden and Depression in Lung Cancer: Association With Inflammation.

Authors:  Daniel C McFarland; Devika R Jutagir; Andrew H Miller; William Breitbart; Christian Nelson; Barry Rosenfeld
Journal:  J Natl Compr Canc Netw       Date:  2020-04       Impact factor: 11.908

2.  Peripheral proinflammatory markers are upregulated in abstinent alcohol-dependent patients but are not affected by cognitive bias modification: Preliminary findings.

Authors:  Jeanelle Portelli; Corinde E Wiers; Xiaobai Li; Sara L Deschaine; Gray R McDiarmid; Felix Bermpohl; Lorenzo Leggio
Journal:  Drug Alcohol Depend       Date:  2019-09-11       Impact factor: 4.492

3.  Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication.

Authors:  Jess G Fiedorowicz; Jill M Cyranowski; Zhuangzhuang Liu; Holly A Swartz
Journal:  Neurol Psychiatry Brain Res       Date:  2019-08-10

4.  Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.

Authors:  Franziska Holtdirk; Anja Mehnert; Mario Weiss; Johannes Mayer; Björn Meyer; Peter Bröde; Maren Claus; Carsten Watzl
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

5.  Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.

Authors:  Jonathan Savitz; Bart N Ford; Hung-Wen Yeh; Elisabeth Akeman; Kelly Cosgrove; Ashley N Clausen; Christopher Martell; Namik Kirlic; Jessica Santiago; T Kent Teague; Michael R Irwin; Martin P Paulus; Robin L Aupperle
Journal:  Psychol Med       Date:  2020-11-25       Impact factor: 10.592

6.  Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review.

Authors:  Avni Jain; Ruth Ann Marrie; Leigh Anne Shafer; Lesley A Graff; Scott B Patten; Renée El-Gabalawy; Jitender Sareen; James M Bolton; John D Fisk; Charles N Bernstein
Journal:  Crohns Colitis 360       Date:  2019-12-19

7.  To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2.

Authors:  Eva M J Peters; Manfred Schedlowski; Carsten Watzl; Ulrike Gimsa
Journal:  Neurobiol Stress       Date:  2021-01-27

8.  Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders.

Authors:  Xiao Wang; Kristina Sundquist; Karolina Palmér; Anna Hedelius; A A Memon; Jan Sundquist
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

9.  The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease-results from the SUPRIM-trial.

Authors:  Erik M G Olsson; Fredrika Norlund; Ronnie Pingel; Gunilla Burell; Mats Gulliksson; Anders Larsson; Bo Karlsson; Kurt Svärdsudd; Claes Held
Journal:  Ups J Med Sci       Date:  2018-08-08       Impact factor: 2.384

Review 10.  Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments.

Authors:  Elisabetta Maffioletti; Alessandra Minelli; Daniela Tardito; Massimo Gennarelli
Journal:  Genes (Basel)       Date:  2020-09-18       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.